Scalable Manufacturing of Clinical-Grade Differentiated Cardiomyocytes Derived from Human-Induced Pluripotent Stem Cells for Regenerative Therapy

0
166
Scientists discuss the future directions for realizing hPSC-based cardiac regenerative therapy.
[Cell Proliferation]
Full Article